Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥10.5bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥18.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥9.1bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥1.7bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥1.2bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.8bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥2.5bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.8bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥1.3bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.6bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥848m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥926m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥30.1bnat 2023-09-30Cons.Assets
Total assets¥29.0bnat 2023-03-31Cons.Assets
Total assets¥27.5bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.5bnat 2023-09-30Cons.Liabilities
Total liabilities¥6.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥22.5bnat 2023-09-30Cons.Net assets
Net assets / equity¥22.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥21.4bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥13.3bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥12.8bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥13.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥12.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥11.9bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.9bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥149m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥551m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥232m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥985m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥500m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥486m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥155.762023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.272023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥214.782022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥110.62022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio71.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio72.4%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥194m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-09-30¥10.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥10.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.7bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥138m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥1.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥9.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥9.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 505
ItemContextValueUnit
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration859000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration729000JPY
Other comprehensive incomePrior1YTDDuration119901000JPY
Other comprehensive incomeCurrentYTDDuration158270000JPY
Comprehensive incomePrior1YTDDuration1046168000JPY
Comprehensive incomeCurrentYTDDuration1386338000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration921435000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration1286059000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration124732000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration100279000JPY
Income before income taxesPrior1YTDDuration1324331000JPY
Income before income taxesCurrentYTDDuration1790855000JPY
Depreciation and amortization ope cfPrior1YTDDuration192021000JPY
Depreciation and amortization ope cfCurrentYTDDuration208740000JPY
Amortization of goodwill ope cfPrior1YTDDuration18559000JPY
Amortization of goodwill ope cfCurrentYTDDuration18559000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration1653000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-792000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration9178000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration2436000JPY
Increase decrease in provision for share based payments ope cfPrior1YTDDuration-JPY
Increase decrease in provision for share based payments ope cfCurrentYTDDuration43300000JPY
Interest and dividends income ope cfPrior1YTDDuration-11192000JPY
Interest and dividends income ope cfCurrentYTDDuration-13591000JPY
Interest expenses ope cfPrior1YTDDuration548000JPY
Interest expenses ope cfCurrentYTDDuration1640000JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration-3439000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration-8514000JPY
Loss gain on sales of investment securities ope cfPrior1YTDDuration-JPY
Loss gain on sales of investment securities ope cfCurrentYTDDuration-22327000JPY
Subsidy income2 ope cfPrior1YTDDuration-JPY
Subsidy income2 ope cfCurrentYTDDuration-1049000JPY
Gain on reversal of subscription rights to shares ope cfPrior1YTDDuration-28720000JPY
Gain on reversal of subscription rights to shares ope cfCurrentYTDDuration-JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-545850000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration-398201000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-12500000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-60461000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-20730000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-22973000JPY
Increase decrease in advances received ope cfPrior1YTDDuration185722000JPY
Increase decrease in advances received ope cfCurrentYTDDuration198362000JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration97180000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration-63182000JPY
Other net ope cfPrior1YTDDuration67613000JPY
Other net ope cfCurrentYTDDuration299013000JPY
Subtotal ope cfPrior1YTDDuration1274375000JPY
Subtotal ope cfCurrentYTDDuration1971814000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration22333000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration18369000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass